期刊文献+

Genistein对人鼻咽癌细胞系CNE抑制增殖和促进凋亡的作用及机制探讨 被引量:2

Effects and mechanism of genistein on the proliferation and apoptosis in human nasopharyngeal carcinoma cell lines CNE
原文传递
导出
摘要 目的:研究genistein对人鼻咽癌细胞系CNE抑制增殖和促进凋亡的作用,探讨其抗癌作用的机制。方法:应用MTT检测不同浓度genistein在不同时间对鼻咽癌细胞系CNE的生长抑制作用;透视电镜下观察鼻咽癌细胞演变过程、凋亡细胞及凋亡小体,应用流式细胞仪分析细胞周期及凋亡率。结果:Genistein可明显抑制CNE细胞的增殖,并且这种抑制作用呈时间及浓度依赖性,随浓度的增加时间的延长抑制作用逐渐增强,尤以200μmol/L组最明显;Genistein诱导鼻咽癌细胞的早期凋亡率随浓度的增加而增强,200μmol/L时为49.9%;FCM分析发现genistein阻断CNE细胞生长于细胞周期的G2/M期;电镜观察到用药后凋亡细胞典型的形态学特征。结论:Genistein对鼻咽癌细胞系CNE的生长有明显的呈时间及浓度依赖性的抑制作用,其阻断细胞的生长主要在细胞周期的G2/M期,并且具有明显诱导CNE细胞凋亡的作用。 Objective: To investigate the effects and mechanism of genistein on proliferation inhibition and onset of apoptosis in nasopharyngeal carcinoma cell line CNE. Method: Antiproliferative effect of genistein against CNE was tested by MTT method.Apoptotic phenotype of CNE was observed by electron microscope.Cell apoptosis percentage and cell cycle phase distribution of CNE were measured by flow cytometric assay. Result: A time dependent and dose dependent proliferation inhibition was demonstrated in CNE,the high potency has the obvious suppression on tumor growth function;Genistein induces nasopharyngeal cancer cell early apoptosis rate but to strengthen along with the density increase,200 μmol/L group is highest,is 49.9%;and genistein induced a G2/ M cell cycle arrest.The characteristic morphological changes of apoptosis in CNE cells was observed after treated by genistein. Conclusion: The time dependent and dosedependent proliferation inhibitory effect of genistein on nasopharyngeal cancer cells.Genisteins mechanism on suppressing effect is probably associated with inducing the cell apoptosis and interving the cell circle of carcinoma cell.The results provide evidence for the potential usefulness of genistein in the prevention and treatment of human nasopharyngeal carcinoma.
出处 《临床耳鼻咽喉头颈外科杂志》 CAS CSCD 北大核心 2011年第18期843-847,共5页 Journal of Clinical Otorhinolaryngology Head And Neck Surgery
关键词 GENISTEIN 鼻咽肿瘤 人鼻咽癌细胞系CNE 抗肿瘤 增殖 凋亡 genistein nasopharyngeal neoplasm human nasopharyngeal carcinoma cell lines CNE anti-tumor proliferation apoptosis
  • 相关文献

参考文献11

  • 1SHAO Z M, WU J, SHEN Z Z,et al. Genistein exerts multiple suppressive effects on human breast carcinoma cells[J]. Cancer Res, 1998,58:4851-4857.
  • 2DAVIS J N, SINGH B, BHUIYAN M, et al. Genistein induced upregulation of p21 wall, downregulation of cyclin B, and induction of apoptosis in prostate cells[J]. Nutrition Cancer, 1998,32:123-131.
  • 3YAN C, HAN R. Genistein suppresses adhesion in duced proteintyrosine phosphorylation and invasion of B162BL6 melanoma cells[J]. Cancer Lett, 1998,129: 117-124.
  • 4ARAI N, STROM A, RAFTER J J, et al. Estrogen receptor beta mRNA in colon cancer cells: growth effects of estrogen and genistein[J]. Biochem Biophys Res Commun,2000,270: 425- 431.
  • 5SHAO Z M, SHEN Z Z, FONTAN A, et al. Genistein's "ER dependent and independent" actions are mediated through ER pathways in ER2positive breast caranoma cell lines [J]. Anticancer Res, 2000, 20: 2409-2416.
  • 6YU Z,TANG Y, HU D, et al. Inhibitory effect of Genistein on mouse colon cancer MC-26 cells involved TGF-betal/Smad pathway[J]. Biochem Biophys Res Commun, 2005,333:827-832.
  • 7SWAMI S, KRISHNAN A V, PEEHL D M, et al. Genistein potentiates the growth inhibitory effects of 1,25-dihydroxyvitamin D(3) in DU145 human prostate cancer cells: role of the direct inhibition of CYP24 enzyme activity [J]. Mol Cell Endocrinol, 2005,241:49-61.
  • 8DING J, SOULE G, OVERMEYER J H, et al. Ty rosine phosphorylation of the Rab24 GTPase in cultured mammalian cells [J]. Biochem Biophys Res Commun, 2003,312:670-675.
  • 9KORSMEYER S J . Bcl22 gene family and the regulation of programmed cell death[J] . Cancer Res,1999, 59:1693-1695.
  • 10GARTEL A L, TYNER A L. Transcriptional regulation of the p21 WAF1/CIPI gene[J]. Exp Cell Res, 1999, 246: 280-289.

同被引文献22

  • 1易俊林,高黎,黄晓东,李素艳,罗京伟,徐国镇.鼻咽癌放射治疗的失败模式[J].中华放射肿瘤学杂志,2004,13(3):145-148. 被引量:89
  • 2XU L,PAN J,WU J,et al. Factors associated with o- verall survival in 1706 patients with nasopharyngeal carcinoma: significance of intensive neoadjuvant chemotherapy and radiation break[J]. Radiother On- col,2010, 96: 94-99.
  • 3GOKCE T,UNLU I, AKCAY C. Evaluation of over- all survival of nasopharyngeal carcinoma patients trea- ted in ten years at a single institution[J]. J BUON, 2010, 15:36-42.
  • 4LEEAW,TUNG S Y,CHUA DT,et al. Random- ized trial of radiotherapy plus concurrent adjuvant chemotherapy vs radiotherapy alone for regionally ad- vanced nasopharyngeal carcinoma[J]. J Natl Cancer Inst,2010,102 : 1188- 1198.
  • 5GAO F, JOSEPH W, HWEE B, et al. Quality-oh life-adiusted survival analysis of concurrent chemora- diotherapy for locally advanced(nonmetastatic) naso- pharyngeal cancer [ J]. Int J Radiation Oncol Biol Phys, 2010,78:454-460.
  • 6LOONG H, MA B, CHAN A. Update on the man- agement and therapeutic monitoring of advanced naso- pharyngeal cancer [J]. Hematol Oncol Clin North Am, 2008, 22:1267-1278.
  • 7HAN F, ZHAO C, HUANG S, et al. Long-term Outcomes and prognostic factors of re-irradiation for locally recurrent nasopharyngeal carcinoma using in- tensity-modulated radiotherapy[J]. Clin Oncol(R Coll Radiol), 2012,24 : 569- 576.
  • 8PALAZI M, ORLANDI E, BOSSI P, et al. Further improvement in outcomes of nasopharyngeal carcino- ma with optimized radiotherapy and induction plus concomitant chemotherapy: an update of the milan ex- perince[J]. Int J Radiation Oncology Biol Phys, 2009, 74: 774-780.
  • 9MEHRA R, COHEN R, BURTNESS B. The role of cetuximab for the treatment of squamous cell carcino- ma of the head and neck[J]. Clin Adv Hematol On- col, 2008,6: 742-750.
  • 10BONNER J, HARARI P, GIRALT J, et al. Radio- therapy plus cetuximab treatment of locoregionally ad- vanced head and neck cancer: one of phase Ⅲ study clinical trialsts 5-year survival data and the relation- ship between eetuximab-induced rash and survival[J]. Lancet Oncol, 2010,11 : 21 - 28.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部